Global Hydrocortisone Butyrate Market Research Report 2022

This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Hydrocortisone butyrate reduces the swelling, itching, and redness that can occur in these types of conditions. The topical solution is used to treat severe dandruff (seborrheic dermatitis). This medication is a medium-strength corticosteroid.
Due to the COVID-19 pandemic, the global Hydrocortisone Butyrate market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Hydrocortisone Butyrate market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Hydrocortisone Butyrate landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Cream accounting for % of the Hydrocortisone Butyrate global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Hydrocortisone Butyrate include Merck, Taro Pharmaceutical Industries, Aurisco, Konzon and Tianjin Jinyao Pharmaceutical Co. Ltd, etc. In terms of revenue, the global 3 largest players have a % market share of Hydrocortisone Butyrate in 2021.
This report focuses on Hydrocortisone Butyrate volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Hydrocortisone Butyrate market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Hydrocortisone Butyrate Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Cream
Solution
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Merck
Taro Pharmaceutical Industries
Aurisco
Konzon
Tianjin Jinyao Pharmaceutical Co. Ltd